Broluidan,
letosteine,
Viscotiol,
Letosteine,
53943-88-7,
Letosteinum,
Letosteina,
UNII-6MVF9U95DW,
Letosteine [INN],
6MVF9U95DW,
Letosteine (INN),
2-[2-(2-ethoxy-2-oxoethyl)sulfanylethyl]-1,3-thiazolidine-4-carboxylic acid,
Viscotiol,
2-(2-((2-Ethoxy-2-oxoethyl)thio)ethyl)thiazolidine-4-carboxylic acid,
2-(2-((Carboxymethyl)thio)ethyl)-4-thiazolidinecarboxylic acid 2-ethyl ester,
4-Thiazolidinecarboxylic acid, 2-(2-((2-ethoxy-2-oxoethyl)thio)ethyl)-,
Letosteinum [INN-Latin],
Letosteina [INN-Spanish],
4-Thiazolidinecarboxylic acid, 2-[2-[(2-ethoxy-2-oxoethyl)thio]ethyl]-,
C10H17NO4S2,
Viscotiol (TN),
EINECS 258-879-3,
AC1Q5UEW,
AC1L2AA7,
SCHEMBL19562,
MLS006010171,
CHEMBL2105044,
CHEBI:88271,
CTK1H0299,
KS-00002WWC,
BCP17027,
2-[2-[(2-ethoxy-2-oxoethyl)thio]ethyl]-4-thiazolidinecarboxylic acid,
MFCD00867663,
AKOS015893059,
API0010497,
DB08939,
KS-5194,
AN-40675,
SMR004701279,
D07380,
K-9749,
943L887,
I04-1446,
BRD-A32597168-001-01-0,
2-[2-(2-ethoxy-2-oxo-ethyl)sulfanylethyl]thiazolidine-4-carboxylic acid,
4-Thiazolidinecarboxylicacid, 2-[2-[(2-ethoxy-2-oxoethyl)thio]ethyl]-,
2-{2-[(2-ethoxy-2-oxoethyl)sulfanyl]ethyl}-1,3-thiazolidine-4-carboxylic acid,
visoctiol,
CID68707,
C10-H17-N-O4-S2,
R082,
2-[2-[(carboxymethyl)thio]ethyl]-4-thiazolidinecarboxylic acid 2-ethyl ester,